Serological markers as predictors of the severity of gastric mucosal atrophy in autoimmune and <i>Helicobacter рylori</i>-associated gastritis
Serum pepsinogens can be used in the Moscow population as a non-invasive marker of gastric mucosa atrophy for the formation of high-risk patient groups for gastric cancer requiring endoscopic examination.
Authors
- А М Велиев
- С Г Хомерики (ORCID: https://orcid.org/0000-0003-4308-8009)
- Karina Nikolskaya (ORCID: https://orcid.org/0000-0002-1477-888X)
- A. Yu. Spasenov
- Д. Н. Андреев (ORCID: https://orcid.org/0000-0002-4007-7112)
- Margarita V. Chebotareva (ORCID: https://orcid.org/0000-0002-0175-4328)
- Д.С. Бордин (ORCID: https://orcid.org/0000-0003-2815-3992)
- E. V. Parfenchikova (ORCID: https://orcid.org/0000-0002-6972-8644)
- Larisa Tsapkova (ORCID: https://orcid.org/0000-0002-7206-8691)
- Irina Voynovan
Institutions
- Moscow Clinical Scientific Center (RU)
- Tver State Medical University (RU)
- Scientific Research Institute of Healthcare Organization and Medical Management (RU)
Publication Details
- Journal
- Terapevticheskii arkhiv
- Published
- 2025-08-28
- DOI
- https://doi.org/10.26442/00403660.2025.08.203343
- Citations
- 2
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01